MTP Building US Commercial Ops On Edaravone
This article was originally published in PharmAsia News
Executive Summary
Japanese mid-sized firm Mitsubishi Tanabe Pharma is building up its independent US commercial operations with a view to conducting the in-house marketing of new products, starting with an ALS therapy.